Applying Shear Wave Elastography for Adjunct Steroid on Tuberculous Lymphadenitis
Tuberculous Lymphadenitis
About this trial
This is an interventional treatment trial for Tuberculous Lymphadenitis focused on measuring tuberculous lymphadenitis, paradoxical upgrading reaction
Eligibility Criteria
Inclusion Criteria: Participants diagnosed of tuberculous lymphadenitis. The diagnosis of tuberculous lymphadenitis must qualify any of the following criteria: microbiological evidence (culture or nucleic acid amplification test) histology specimen featuring caseating granulomatous inflammation with acid-fast bacilli on smear, or clinical response to anti-tuberculosis therapy. Exclusion Criteria: Participants with age < 18 years Diagnoses based on histologic report turned out to be non-tuberculosis mycobacterial infection The tuberculous lymphadenitis involved was surgically removed, without available target to be monitored Participant under systemic (oral or parenteral) steroid therapy. Participant with active hepatitis B virus infection Participant reluctant to be enrolled in the trial
Sites / Locations
- National Taiwan University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Adjunct corticosteroid and standard anti-tuberculosis agent
Standard of care with standard anti-tuberculosis agent
Prednisolone dosing and duration per study protocol
standard anti-tuberculosis agent